The Beth Israel Hospital Association
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 30, 2007 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 7,789 Total Citation Count
- Jun 22, 1981 Earliest Filing
- 104 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
5889038 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compoundsMar 20, 96Mar 30, 99[A61K]
5694934 MR studies in which a paramagnetic gas is administered to a living patientApr 17, 96Dec 09, 97[A61B]
5536636 Methods for identifying a tyrosine phosphatase abnormality associated with neoplastic diseaseFeb 28, 94Jul 16, 96[C07H, C12Q, C12P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2003/0223,970 Methods and compounds for prevention of graft rejectionAbandonedMar 12, 01Dec 04, 03[A61K]
6403077 Treatment regimes featuring an IL-10-containing chimeric polypeptideExpiredNov 06, 97Jun 11, 02[A61K]
6297023 Assay for plasminogen activator inhibitor-1 and tissue plasminogen activator activityExpiredSep 02, 94Oct 02, 01[C12Q]
6113900 Use of IL-2 receptor-targeted therapeutics to inhibit allograft rejection and treat autoimmune disordersExpiredNov 21, 97Sep 05, 00[A61K]
5958403 Methods and compounds for prevention of graft rejectionExpiredJul 11, 94Sep 28, 99[A61K, C12N]
5936138 Gene encoding mutant L3T4 protein which facilitates HIV infection and transgenic mouse expressing such proteinExpiredApr 15, 97Aug 10, 99[C12N]
5916559 Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejectionExpiredDec 11, 96Jun 29, 99[A61K]
5856196 Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses thereforExpiredFeb 16, 95Jan 05, 99[G01N]
5837548 Treatment of inflammation by inhibition of lipid body formationExpiredDec 01, 95Nov 17, 98[G01N]
5789654 Transgenic animals deficient in endogenous .beta..sub.3 -adrenergic receptor and uses thereofExpiredMay 09, 96Aug 04, 98[C12N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
